The bones form the framework of our body. We know that bones protect our vital organs, regulate calcium and phosphorous homeostasis, and function as a site of erythropoiesis. More recently, however, the identification of bone hormones has allowed us to envision bones as endocrine organs too. Within the last few years, the bone hormones osteocalcin and lipocalin 2 have been implicated with glucose and energy metabolism. We systematically reviewed articles surrounding this subject and found a clear relationship between the osteocalcin levels and glucose tolerance and insulin sensitivity. We also found that many journals have shown the detrimental effects of an absences of lipocalin 2 from adipocytes. As osteocalcin administration to mice showed decreased blood glucose levels and promoted glucose tolerance and insulin sensitivity. Future studies could perhaps explore the use of osteocalcin as a supplement for type 2 diabetes.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Alwahsh SM Xu M Seyhan HA Ahmad S Mihm S Ramadori G Schultze FC. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 20 1807–1821 2014.
Bouillon R Bex M Van Herck E Laureys J Dooms L Lesaffre E Ravussin E. Influence of age sex and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80 1194–1202 1995.
de Liefde II van der Klift M de Laet CE van Daele PL Hofman A Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16 1713–1720 2005.
Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54 1291–1297 2011.
Ferron M McKee MD Levine RL Ducy P Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50 568–575 2012.
Flo TH Smith KD Sato S Rodriguez DJ Holmes MA Strong RK Akira S Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 917–921 2004.
Francisco V Pino J Gonzalez-Gay MA Mera A Lago F Gomez R Mobasheri A Gualillo O. Adipokines and inflammation: is it a question of weight? Br J Pharmacol 175 1569–1579 2018.
Giudici KV Fisberg RM Marchioni DML Peters BSE Martini LA. Crosstalk between bone and fat tissue: associations between vitamin D osteocalcin adipokines and markers of glucose metabolism among adolescents. J Am Coll Nutr 36 273–280 2017.
Gomez-Chou SB Swidnicka-Siergiejko AK Badi N Chavez-Tomar M Lesinski GB Bekaii-Saab T Farren MR Mace TA Schmidt C Liu Y Deng D Hwang RF Zhou L Moore T Chatterjee D Wang H Leng X Arlinghaus RB Logsdon CD Cruz-Monserrate Z. Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment. Cancer Res 77 2647–2660 2017.
Guntur AR Rosen CJ. Bone as an endocrine organ. Endocr Pract 18 758–762 2012.
Guo H Jin D Zhang Y Wright W Bazuine M Brockman D Bernlohr D Chen X. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59 1376–1385 2010.
Herman W. The global burden of diabetes: An overview. In: Diabetes mellitus in developing countries and under-served communities (Ed. S. Dagogo-Jack) Springer International Publishing Switzerland pp. 1–5 2017.
Holt SK Karyadi DM Kwon EM Stanford JL Nelson PS Ostrander EA. Association of Megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin Cancer Res 14 3823–3831 2008.
Hvidberg V Jacobsen C Strong RK Cowland JB Moestrup SK Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579 773–777 2005.
Ivers RQ Cumming RG Mitchell P Peduto AJ; Blue Mountains Eye Study. Diabetes and risk of fracture. Diabetes Care 24 1198–1203 2001.
Janghorbani M Van Dam RM Willett WC Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166 495–505 2007.
Kanazawa I Yamaguchi T Yamauchi M Yamamoto M Kurioka S Yano S Sugimoto T. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22 187–194 2011.
Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World J Diabetes 6 1345–1354 2015.
Karsenty G Oury F Biology without walls: the novel endocrinology of bone. Annu Rev Physiol 74 87–105 2012.
Lambertz J Berger T Mak TW van Helden J Weiskirchen R. Lipocalin-2 in fructose-induced fatty liver disease. Front Physiol 8 964 2017.
Lee NK Sowa H Hinoi E Ferron M Ahn JD Confavreux C Dacquin R Mee PJ McKee MD Jung DY Zhang Z Kim JK Mauvais-Jarvis F Ducy P Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 130 456–469 2007.
Liang Y Tan A Liang D Yang X Liao M Gao Y Jiang Y Yao Z Lin X Lu Z Wu C Zhang S Hu Y Qin X Mo Z Li H Zhang H. Low osteocalcin level is a risk factor for impaired glucose metabolism in a Chinese male population. J Diabetes Investig 7 522–528 2016.
Marzolo PM Farfan P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res 44 89–105 2011.
Mera P Ferron M Mosialou I. Regulation of energy metabolism by bone-derived hormones. Cold Spring Harb Perspect Med 8 a031666 2018.
Mizokami A Wang D Tanaka M Gao J Takeuchi H Matsui T Hirata M. An extract from pork bones containing osteocalcin improves glucose metabolism in mice by oral administration. Biosci Biotechnol Biochem 80 2176–2183 2016.
Miyamoto T Asaka R Suzuki A Takatsu A Kashima H Shiozawa T. Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17 SLC22A17) and its prognostic significance in endometrial carcinoma. Exp Mol Pathol 91 563–568 2011.
Mosialou I Shikhel S Liu J Maurizi A Luo N He Z Huang Y Zong H Friedman R Barasch J Lanzano P Deng L Leibel R Rubin M Nickolas T Chung W Zeltser L Williams K Pessin J Kousteni S. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543 385–390 2017.
Neumann T Lodes S Kastner B Franke S Kiehntopf M Lehmann T Muller UA Wolf G Samann A. Osteocalcin adipokines and their associations with glucose metabolism in type 1 diabetes. Bone 82 50–55 2016.
Neve A Corrado A Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 228 1149–1153 2013.
Pi M Wu Y Quarles LD. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo. J Bone Miner Res 26 1680–1683 2011.
Pi M Kapoor K Ye R Nishimoto SK Smith JC Baudry J Quarles LD. Evidence for osteocalcin binding and activation of GPRC6A in β-cells. Endocrinology 157 1866–1880 2016.
Rached MT Kode A Silva BC Jung DY Gray S Ong H Paik JH DePinho RA Kim JK Karsenty G Kousteni S. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 120 357–368 2010.
Saleem U Mosley TH Jr Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance adipokine levels and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 30 1474–1478 2010.
Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 18 427–444 2007.
Visscher V Rassekh SR Sandor GS Caron HN van Dalen EC Kremer LC van der Pal HJ Rogers PC Rieder MJ Carleton BC Hayden MR Ross CJ; CPNDS consortium. Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics 16 1065–1076 2015.
Wang Y Zhou Y Graves DT. FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014 925350 2014.
Wei J Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord 16 93–98 2015.
Yan QW Yang Q Mody N Graham TE Hsu CH Xu Z Houstis NE Kahn BB Rosen ED. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56 2533–2540 2007.